Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1470 (100th)

Compassionate Pain Relief Act

referredUnited States· United States Congress· EN

Introduced

5 March 1987

Last action

12 March 1987 · Referred

Status

Referred to Subcommittee on Health and the Environment.

Sponsors

Rep. Waxman, Henry A. [D-CA-33], Rep. Hughes, William J. [D-NJ-2], Rep. Walgren, Doug [D-PA-18], Sen. Akaka, Daniel K. [D-HI], Rep. Ford, William D. [D-MI-13], Rep. Gunderson, Steve [R-WI-3], Rep. Levine, Mel [D-CA-27], Rep. Martinez, Matthew G. [D-CA-31], Rep. McKinney, Stewart B. [R-CT-4], Rep. Mineta, Norman Y. [D-CA-15], Rep. Obey, David R. [D-WI-7], Rep. Smith, Lawrence [D-FL-16], Sen. Smith, Bob [R-NH], Rep. Weiss, Ted [D-NY-17], Rep. Udall, Morris K. [D-AZ-2], Rep. Yates, Sidney R. [D-IL-9], Sen. Gregg, Judd [R-NH], Rep. Moody, Jim [D-WI-5], Rep. Dicks, Norman D. [D-WA-6], Rep. Feighan, Edward F. [D-OH-19], Rep. Sharp, Philip R. [D-IN-2], Rep. Jacobs, Andrew, Jr. [D-IN-10], Rep. Gibbons, Sam [D-FL-11], Rep. Green, S. William [R-NY-15], Rep. Bustamante, Albert G. [D-TX-23], Rep. Gordon, Bart [D-TN-6], Rep. Kaptur, Marcy [D-OH-9], Rep. Applegate, Douglas [D-OH-18], Rep. Brown, George E., Jr. [D-CA-42], Rep. Gray, Kenneth J. [D-IL-22], Rep. Wilson, Charles [D-TX-2], Rep. Frank, Barney [D-MA-4], Rep. Traficant, James A., Jr. [D-OH-17], Rep. Ackerman, Gary L. [D-NY-5], Rep. Bates, Jim [D-CA-44], Rep. Brennan, Joseph E. [D-ME-1], Rep. Solarz, Stephen J. [D-NY-13], Rep. Crockett, George W., Jr. [D-MI-13], Rep. Studds, Gerry E. [D-MA-10], Rep. Wise, Robert E., Jr. [D-WV-2], Sen. Markey, Edward J. [D-MA], Rep. Spence, Floyd [R-SC-2], Rep. Ireland, Andrew P. [R-FL-10], Rep. Pelosi, Nancy [D-CA-11], Rep. Sawyer, Tom [D-OH-14], Rep. Price, Melvin [D-IL-21]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Summary

Compassionate Pain Relief Act - Directs the Secretary of Health and Human Services to establish a program under which heroin shall be made available to individuals for the relief of pain from terminal cancer. Directs the Secretary, acting through the Commissioner of the Food and Drug Administration, to provide for the manufacture of heroin for such program. Directs the Attorney General to promulgate regulations making heroin available for use in such program. Directs the Secretary to assure the purity of such drug. Permits physicians, hospital pharmacies, and hospice pharmacies registered under the Controlled Substances Act to prescribe heroin to terminally ill cancer patients. Requires the registration, by the Attorney General, of: (1) manufacturers of heroin to be used in the program; (2) hospice and hospital pharmacies which dispense such drug; and (3) physicians who prescribe it. Provides penalties for those who knowingly violate regulations prescribed by the Secretary. Requires the Secretary to report to specified congressional committees regarding: (1) activities under the program; and (2) research and training in pain management funded by the National Institutes of Health. Provides for the program's termination.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 5 March 1987

    Introduced

    Referred to House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 5 March 1987

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 5 March 1987

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 12 March 1987

    Referred

    Referred to Subcommittee on Health and the Environment.

    Source: Committee

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.